Thomas J. Cumbo

1.1k total citations
21 papers, 891 citations indexed

About

Thomas J. Cumbo is a scholar working on Pharmacology, Applied Microbiology and Biotechnology and Molecular Medicine. According to data from OpenAlex, Thomas J. Cumbo has authored 21 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 7 papers in Applied Microbiology and Biotechnology and 6 papers in Molecular Medicine. Recurrent topics in Thomas J. Cumbo's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Use and Resistance (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Thomas J. Cumbo is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Use and Resistance (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Thomas J. Cumbo collaborates with scholars based in United States. Thomas J. Cumbo's co-authors include Jerome J. Schentag, Joseph A. Paladino, Donald P. Reitberg, William J. Jusko, Mary C. Birmingham, John W. Vance, James R. Carr, Judith M. Hyatt, Louise M. Gerbracht and Charles H. Ballow and has published in prestigious journals such as Cancer, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Thomas J. Cumbo

21 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Cumbo United States 13 464 291 214 212 210 21 891
C H Nightingale United States 17 657 1.4× 427 1.5× 325 1.5× 115 0.5× 192 0.9× 37 1.0k
Harald H. Reinhart United States 17 267 0.6× 325 1.1× 263 1.2× 168 0.8× 185 0.9× 26 880
Y. Péan France 15 327 0.7× 417 1.4× 240 1.1× 247 1.2× 283 1.3× 38 998
Thomas R. Beam United States 17 247 0.5× 401 1.4× 166 0.8× 66 0.3× 167 0.8× 45 869
Cynthia L. Fowler United States 16 617 1.3× 639 2.2× 360 1.7× 118 0.6× 258 1.2× 21 1.1k
Gilbert M. Rose United States 10 405 0.9× 198 0.7× 532 2.5× 181 0.9× 357 1.7× 14 1.1k
Alan H. Mutnick United States 17 212 0.5× 270 0.9× 253 1.2× 134 0.6× 385 1.8× 41 1.1k
H. Lode Germany 17 619 1.3× 545 1.9× 407 1.9× 123 0.6× 256 1.2× 47 1.4k
Nalinee Aswapokee Thailand 16 430 0.9× 644 2.2× 440 2.1× 183 0.9× 241 1.1× 47 1.3k
Kyle Vance‐Bryan United States 15 408 0.9× 232 0.8× 148 0.7× 51 0.2× 314 1.5× 35 886

Countries citing papers authored by Thomas J. Cumbo

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Cumbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Cumbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Cumbo more than expected).

Fields of papers citing papers by Thomas J. Cumbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Cumbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Cumbo. The network helps show where Thomas J. Cumbo may publish in the future.

Co-authorship network of co-authors of Thomas J. Cumbo

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Cumbo. A scholar is included among the top collaborators of Thomas J. Cumbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Cumbo. Thomas J. Cumbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carr, James R., Paul Fitzpatrick, Joseph L. Izzo, et al.. (1997). Changing the Infection Control Paradigm From Off-Line to Real Time The Experience at Millard Fillmore Health System. Infection Control and Hospital Epidemiology. 18(4). 255–259. 12 indexed citations
3.
Schentag, Jerome J., Mary C. Birmingham, Joseph A. Paladino, et al.. (1997). In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.. PubMed. 12(4). 278–93. 23 indexed citations
4.
5.
Schentag, Jerome J., Charles H. Ballow, Joseph A. Paladino, et al.. (1993). Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagnostic Microbiology and Infectious Disease. 16(3). 255–264. 96 indexed citations
6.
Paladino, Joseph A., et al.. (1993). Abbreviating the Duration of Intravenous Antibiotics with Oral Fluoroquinolones†. Drugs. 45(Supplement 3). 475–475. 3 indexed citations
7.
Schentag, Jerome J., Alan Forrest, Thomas F. Goss, et al.. (1993). Ciprofloxacin Eradicates Respiratory Tract Bacteria More Rapidly than Cephalosporins in Patients with Nosocomial Pneumonia†. Drugs. 45(Supplement 3). 473–473. 1 indexed citations
8.
9.
Paladino, Joseph A., et al.. (1991). Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. The American Journal of Medicine. 91(5). 462–470. 142 indexed citations
10.
Peloquin, Charles A., Thomas J. Cumbo, & J J Schentag. (1991). Kinetics and dynamics of tobramycin action in patients with bacteriuria given single doses. Antimicrobial Agents and Chemotherapy. 35(6). 1191–1195. 5 indexed citations
11.
Nix, David E., Mark F. Sands, Charles A. Peloquin, et al.. (1987). Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.. PubMed. 82(4A). 352–6. 33 indexed citations
12.
Reitberg, Donald P., Thomas J. Cumbo, A. Ian Smith, & Jerome J. Schentag. (1984). Effect of protein binding on cefmenoxime steady-state kinetics in critical patients. Clinical Pharmacology & Therapeutics. 35(1). 64–73. 17 indexed citations
13.
Schentag, Jerome J., Donald P. Reitberg, & Thomas J. Cumbo. (1984). Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial Pneumonia. The American Journal of Medicine. 77(6). 34–42. 130 indexed citations
14.
Reitberg, Donald P., Thomas J. Cumbo, & Jerome J. Schentag. (1984). Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients. Journal of Antimicrobial Chemotherapy. 14(1). 81–91. 8 indexed citations
15.
Dillon, William P., et al.. (1982). Prolonged use of a diaphragm and toxic shock syndrome. Fertility and Sterility. 38(2). 248–250. 22 indexed citations
16.
Edwards, David J., Antoinette Mangione, Thomas J. Cumbo, & J J Schentag. (1981). Predicted tissue accumulation of netilmicin in patients. Antimicrobial Agents and Chemotherapy. 20(6). 714–717. 11 indexed citations
17.
Schentag, Jerome J., et al.. (1978). Accumulation Pharmacokinetics of Tobramycin. Antimicrobial Agents and Chemotherapy. 13(4). 649–656. 55 indexed citations
18.
Schentag, Jerome J., et al.. (1978). Comparative tissue accumulation of gentamicin and tobramycin in patients. Journal of Antimicrobial Chemotherapy. 4(suppl A). 23–30. 31 indexed citations
19.
Schentag, Jerome J., William J. Jusko, John W. Vance, et al.. (1977). Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics. 5(6). 559–577. 116 indexed citations
20.
Newman, Richard P., Lawrence Jacobs, & Thomas J. Cumbo. (1977). Myelopathy due to spinal metastasis from adenocarcinoma of the gallbladder. Cancer. 40(5). 2338–2342. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C H Nightingale Breakdown of academic impact, for papers by Harald H. Reinhart Breakdown of academic impact, for papers by Y. Péan Breakdown of academic impact, for papers by Thomas R. Beam Breakdown of academic impact, for papers by Cynthia L. Fowler Breakdown of academic impact, for papers by Gilbert M. Rose Breakdown of academic impact, for papers by Alan H. Mutnick Breakdown of academic impact, for papers by H. Lode Breakdown of academic impact, for papers by Nalinee Aswapokee Breakdown of academic impact, for papers by Kyle Vance‐Bryan
Rankless by CCL
2026